TC
GILD icon

Titleist Capital’s Gilead Sciences GILD Stock Holding History

Titleist Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$270K Buy
+3,141
New +$249K 0.06% 191
2022
Q1 		– Sell
-2,866
Closed -$208K – 270
2021
Q4 		$208K Buy
+2,866
New +$197K 0.04% 223

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Titleist Capital's GILD Position: Q4 2022 in Review

Titleist Capital opened a new position in Gilead Sciences (GILD) in Q4 2022: 3,141 shares worth $270K. The stake represents 0.06% of the portfolio and ranks #191 among its holdings. This is a return to the name: Titleist Capital previously reported a position in GILD as recently as Q4 2021.

Titleist Capital first reported a position in GILD in Q4 2021 and has held it in 2 quarters since. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Titleist Capital held 3,141 shares of Gilead Sciences worth $270K as of Q4 2022.
  • Gilead Sciences was a new Titleist Capital position in Q4 2022.
  • Gilead Sciences made up 0.06% of Titleist Capital's portfolio in Q4 2022, its #191 holding.
  • Titleist Capital first reported a position in Gilead Sciences in Q4 2021 and has held it in 2 quarters since.
  • 1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Titleist Capital's 13F filing for Q4 2022, filed 12 Jan 2023.